1 | case | 23,238 |
2 | 4-dose | 15 |
3 | s-9 | 15 |
4 | non-screening | 12 |
5 | metasynthesis | 9 |
6 | haloperidol-promethazine | 8 |
7 | belmont | 7 |
8 | postinfant | 7 |
9 | novolog | 5 |
10 | forct | 4 |
11 | finesse-angio | 3 |
12 | o₂-n₂o | 3 |
13 | post-infant | 3 |
14 | trials/case | 3 |
15 | two-article | 3 |
16 | use-plus | 3 |
17 | aisle | 2 |
18 | announcement-based | 2 |
19 | consultant-verified | 2 |
20 | eurohyp-1 | 2 |
21 | heat-rate | 2 |
22 | hospital-referred | 2 |
23 | lead-2 | 2 |
24 | necrox | 2 |
25 | protein-mineral | 2 |
26 | symptoms.we | 2 |
27 | triangular-skin-flap | 2 |
28 | weblog | 2 |
29 | 'skill | 1 |
30 | 1,644,220 | 1 |
31 | 12-part | 1 |
32 | 2,3,4-month | 1 |
33 | 2-aminonaphthalimide | 1 |
34 | 2-aryl-1,8-naphthyridin-4-one | 1 |
35 | 2-aryl-3h-indol-3-one | 1 |
36 | 2-aryloctahydrophenanthrene-2,3,7-triol | 1 |
37 | 26-patient | 1 |
38 | 28-case | 1 |
39 | 2dt2w-ssfse | 1 |
40 | 32-trial | 1 |
41 | 4-3-1-3-3-1 | 1 |
42 | 400-patient | 1 |
43 | 6-part | 1 |
44 | 900-patient | 1 |
45 | 90i | 1 |
46 | acid/antibiotic | 1 |
47 | active/one | 1 |
48 | after-case | 1 |
49 | anatomophological | 1 |
50 | androst-5-ene | 1 |
51 | anthrol | 1 |
52 | arms.case | 1 |
53 | athlete-specific | 1 |
54 | bis-alkylguanidine | 1 |
55 | blood-coagulating | 1 |
56 | cfu/sample | 1 |
57 | conseceutive | 1 |
58 | dual-polymer | 1 |
59 | extra-continental | 1 |
60 | flame-wrapping | 1 |
61 | four-case | 1 |
62 | full-published | 1 |
63 | goodbug | 1 |
64 | herbal/antipsychotic | 1 |
65 | historical/ecological | 1 |
66 | icss-mri | 1 |
67 | indanamine | 1 |
68 | indolinyl | 1 |
69 | inhibitor-hyperkalaemia | 1 |
70 | interrupted-time | 1 |
71 | kcr | 1 |
72 | kofoidian | 1 |
73 | multi-allergen | 1 |
74 | n-phenethylamino | 1 |
75 | perphenylated | 1 |
76 | piperazinecarboxamide | 1 |
77 | pointof-view | 1 |
78 | program-atpiii | 1 |
79 | pseudo-pathologic | 1 |
80 | ramdomised | 1 |
81 | self-/proxy | 1 |
82 | sleep/hrqol | 1 |
83 | specific/holistic | 1 |
84 | study-like | 1 |
85 | tap1-abcc9 | 1 |
86 | temperature-mode | 1 |
87 | temporal-controlled | 1 |
88 | thiuram | 1 |
89 | tripentone | 1 |
90 | very-successful | 1 |
1 | 'skill | 1 |
2 | 1,644,220 | 1 |
3 | 12-part | 1 |
4 | 2,3,4-month | 1 |
5 | 2-aminonaphthalimide | 1 |
6 | 2-aryl-1,8-naphthyridin-4-one | 1 |
7 | 2-aryl-3h-indol-3-one | 1 |
8 | 2-aryloctahydrophenanthrene-2,3,7-triol | 1 |
9 | 26-patient | 1 |
10 | 28-case | 1 |
11 | 2dt2w-ssfse | 1 |
12 | 32-trial | 1 |
13 | 4-3-1-3-3-1 | 1 |
14 | 4-dose | 15 |
15 | 400-patient | 1 |
16 | 6-part | 1 |
17 | 900-patient | 1 |
18 | 90i | 1 |
19 | acid/antibiotic | 1 |
20 | active/one | 1 |
21 | after-case | 1 |
22 | aisle | 2 |
23 | anatomophological | 1 |
24 | androst-5-ene | 1 |
25 | announcement-based | 2 |
26 | anthrol | 1 |
27 | arms.case | 1 |
28 | athlete-specific | 1 |
29 | belmont | 7 |
30 | bis-alkylguanidine | 1 |
31 | blood-coagulating | 1 |
32 | case | 23,238 |
33 | cfu/sample | 1 |
34 | conseceutive | 1 |
35 | consultant-verified | 2 |
36 | dual-polymer | 1 |
37 | eurohyp-1 | 2 |
38 | extra-continental | 1 |
39 | finesse-angio | 3 |
40 | flame-wrapping | 1 |
41 | forct | 4 |
42 | four-case | 1 |
43 | full-published | 1 |
44 | goodbug | 1 |
45 | haloperidol-promethazine | 8 |
46 | heat-rate | 2 |
47 | herbal/antipsychotic | 1 |
48 | historical/ecological | 1 |
49 | hospital-referred | 2 |
50 | icss-mri | 1 |
51 | indanamine | 1 |
52 | indolinyl | 1 |
53 | inhibitor-hyperkalaemia | 1 |
54 | interrupted-time | 1 |
55 | kcr | 1 |
56 | kofoidian | 1 |
57 | lead-2 | 2 |
58 | metasynthesis | 9 |
59 | multi-allergen | 1 |
60 | n-phenethylamino | 1 |
61 | necrox | 2 |
62 | non-screening | 12 |
63 | novolog | 5 |
64 | o₂-n₂o | 3 |
65 | perphenylated | 1 |
66 | piperazinecarboxamide | 1 |
67 | pointof-view | 1 |
68 | post-infant | 3 |
69 | postinfant | 7 |
70 | program-atpiii | 1 |
71 | protein-mineral | 2 |
72 | pseudo-pathologic | 1 |
73 | ramdomised | 1 |
74 | s-9 | 15 |
75 | self-/proxy | 1 |
76 | sleep/hrqol | 1 |
77 | specific/holistic | 1 |
78 | study-like | 1 |
79 | symptoms.we | 2 |
80 | tap1-abcc9 | 1 |
81 | temperature-mode | 1 |
82 | temporal-controlled | 1 |
83 | thiuram | 1 |
84 | trials/case | 3 |
85 | triangular-skin-flap | 2 |
86 | tripentone | 1 |
87 | two-article | 3 |
88 | use-plus | 3 |
89 | very-successful | 1 |
90 | weblog | 2 |
1 | 1,644,220 | 1 |
2 | 4-3-1-3-3-1 | 1 |
3 | eurohyp-1 | 2 |
4 | lead-2 | 2 |
5 | s-9 | 15 |
6 | tap1-abcc9 | 1 |
7 | inhibitor-hyperkalaemia | 1 |
8 | athlete-specific | 1 |
9 | pseudo-pathologic | 1 |
10 | herbal/antipsychotic | 1 |
11 | acid/antibiotic | 1 |
12 | specific/holistic | 1 |
13 | full-published | 1 |
14 | consultant-verified | 2 |
15 | temporal-controlled | 1 |
16 | hospital-referred | 2 |
17 | announcement-based | 2 |
18 | ramdomised | 1 |
19 | perphenylated | 1 |
20 | piperazinecarboxamide | 1 |
21 | 2-aminonaphthalimide | 1 |
22 | temperature-mode | 1 |
23 | study-like | 1 |
24 | two-article | 3 |
25 | cfu/sample | 1 |
26 | aisle | 2 |
27 | interrupted-time | 1 |
28 | androst-5-ene | 1 |
29 | bis-alkylguanidine | 1 |
30 | indanamine | 1 |
31 | haloperidol-promethazine | 8 |
32 | 2-aryl-3h-indol-3-one | 1 |
33 | 2-aryl-1,8-naphthyridin-4-one | 1 |
34 | active/one | 1 |
35 | tripentone | 1 |
36 | case | 23,238 |
37 | 28-case | 1 |
38 | after-case | 1 |
39 | four-case | 1 |
40 | arms.case | 1 |
41 | trials/case | 3 |
42 | 2dt2w-ssfse | 1 |
43 | 4-dose | 15 |
44 | heat-rate | 2 |
45 | conseceutive | 1 |
46 | symptoms.we | 2 |
47 | non-screening | 12 |
48 | flame-wrapping | 1 |
49 | blood-coagulating | 1 |
50 | weblog | 2 |
51 | novolog | 5 |
52 | goodbug | 1 |
53 | 2,3,4-month | 1 |
54 | 90i | 1 |
55 | program-atpiii | 1 |
56 | icss-mri | 1 |
57 | historical/ecological | 1 |
58 | anatomophological | 1 |
59 | 32-trial | 1 |
60 | protein-mineral | 2 |
61 | extra-continental | 1 |
62 | 'skill | 1 |
63 | 2-aryloctahydrophenanthrene-2,3,7-triol | 1 |
64 | sleep/hrqol | 1 |
65 | anthrol | 1 |
66 | very-successful | 1 |
67 | indolinyl | 1 |
68 | thiuram | 1 |
69 | kofoidian | 1 |
70 | multi-allergen | 1 |
71 | finesse-angio | 3 |
72 | n-phenethylamino | 1 |
73 | o₂-n₂o | 3 |
74 | triangular-skin-flap | 2 |
75 | kcr | 1 |
76 | dual-polymer | 1 |
77 | metasynthesis | 9 |
78 | use-plus | 3 |
79 | forct | 4 |
80 | post-infant | 3 |
81 | postinfant | 7 |
82 | 400-patient | 1 |
83 | 900-patient | 1 |
84 | 26-patient | 1 |
85 | belmont | 7 |
86 | 12-part | 1 |
87 | 6-part | 1 |
88 | pointof-view | 1 |
89 | necrox | 2 |
90 | self-/proxy | 1 |